Statins and Cancer Mortality in NAFLD: Is it Too Early to Rejoice?

J Clin Gastroenterol. 2021 Aug 1;55(7):638-639. doi: 10.1097/MCG.0000000000001570.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cardiovascular Diseases*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors* / adverse effects
  • Neoplasms*
  • Non-alcoholic Fatty Liver Disease* / drug therapy

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors